Enhabit (NYSE:EHAB) Stock Rating Upgraded by Jefferies Financial Group

Enhabit (NYSE:EHAB) was upgraded by equities research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat Ratings reports. The firm presently has a $9.50 price target on the stock, up from their previous price target of $8.25. Jefferies Financial Group’s target price would suggest a potential upside of 10.59% from the company’s previous close.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Enhabit currently has a consensus rating of “Hold” and a consensus target price of $9.40.

Enhabit Stock Down 1.8 %

EHAB stock opened at $8.59 on Monday. Enhabit has a 52 week low of $6.85 and a 52 week high of $11.74. The company has a market capitalization of $431.94 million, a price-to-earnings ratio of -3.70 and a beta of 1.89. The firm’s 50-day moving average is $7.50 and its two-hundred day moving average is $8.31. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter last year, the firm posted $0.03 earnings per share. On average, analysts forecast that Enhabit will post 0.22 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. WINTON GROUP Ltd purchased a new position in shares of Enhabit in the second quarter worth approximately $955,000. Marshall Wace LLP purchased a new position in shares of Enhabit in the second quarter worth approximately $1,941,000. Systematic Financial Management LP increased its position in shares of Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after acquiring an additional 199,235 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Enhabit in the third quarter worth approximately $215,000. Finally, AREX Capital Management LP grew its position in Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after purchasing an additional 59,353 shares in the last quarter.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.